๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

โœ Scribed by Lacaille, Diane ;Guh, Daphne P. ;Abrahamowicz, Michal ;Anis, Aslam H. ;Esdaile, John M.

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
88 KB
Volume
59
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

American College of Rheumatology 2008 re
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
โœ Saag, Kenneth G. ;Teng, Gim Gee ;Patkar, Nivedita M. ;Anuntiyo, Jeremy ;Finney, ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 315 KB ๐Ÿ‘ 2 views

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be v

Medical resource use and costs among rhe
Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy
โœ Griffiths, Robert I. ;Bar-Din, Miriam ;MacLean, Catherine H. ;Sullivan, Erin M. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 201 KB ๐Ÿ‘ 1 views

## Objective: To identify costs among rheumatoid arthritis (ra) patients receiving alternative disease-modifying antirheumatic drug (dmard) therapies. ## Methods: Using managed care organization data, we identified members who (a) were prescribed any dmard therapy for two consecutive months betwe